This investigation reveals the impact of tea polyphenols on CYP450s in HepG2 cells, suggesting metabolic interactions with medications.
Introduction Tea, one of the world's three major beverages, exhibits antioxidant, antitumour, and cardiovascular benefits, primarily due to its polyphenolic components. However, the roles of tea polyphenols on the modulation of cytochrome P450 enzymes (CYP450s) are not well documented. Therefore, this study investigates the regulatory effects of tea polyphenols on CYP450s in HepG2 cells. Methods High-performance liquid chromatography (HPLC) was used to analyse the compositions of tea polyphenol extracts from Longjing green tea (unfermented), Tieguanyin oolong tea (semifermented) and Dianhong black tea (fully fermented). HepG2 cells were treated with these extracts and their major polyphenolic constituents (EGCG, EGC, ECG, TF, TF-3-G, and TF-3′-G), and the mRNA and protein expression levels of CYP3A4, CYP2E1, CYP2C9 and CYP1A2 were measured using real-time RT–PCR and Western blotting. Results Significant regulation of CYP450 mRNA and protein expression by the three tea polyphenol extracts was observed, and enzyme inhibition was more prevalent than induction, with large contributions from the major monomers, including EGCG, EGC, and ECG. These findings indicate that interactions based on metabolism might occur when tea polyphenols are combined with medications. Conclusion This study provides evidence that tea polyphenols significantly affect CYP450 enzyme expression, offering insights into the potential interactions between tea consumption and drug metabolism.
No takes yet. Share an insight, caveat, or question.
Zuo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: